Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: Role of calcium and transmetallation

BioMetals

Volumn 11, Issue 2, 1998, Pages 113-123

  Idée, Jean Marc ^a   Berthommier, Christine ^a   Goulas, Valérie ^a   Corot, Claire ^a   Santus, Robin ^a   Hermine, Chantai ^a   Schaefer, Michel ^a   Bonnemain, Bruno ^a  

^a Laboratoire Guerbet   (France)

Author keywords

Calcuim; Gadolinium; Magnetic resonance imaging contrast media; Transmetallation

Indexed keywords

CALCIUM; CONTRAST MEDIUM; DILTIAZEM; GADOLINIUM CHELATE; GLUCOSE; MACROCYCLIC COMPOUND; PENTETATE ZINC; PENTETIC ACID; PHENTOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART STROKE VOLUME; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOLALITY; RAT;

ANIMALS; BLOOD PRESSURE; CALCIUM; CHELATING AGENTS; CONTRAST MEDIA; DILTIAZEM; GADOLINIUM; GADOLINIUM DTPA; HEMODYNAMIC PROCESSES; HETEROCYCLIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MALE; ORGANOMETALLIC COMPOUNDS; PHENTOLAMINE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0031936310     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009225911668     Document Type: Article

References (38)

1. Akre BT, Dunkel JA, Hustvedt SO, Refsum H. 1997 Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart. Acad Radiol 4, 283-291.
2. Anonymous 1989 In: Reynolds JEF ed. Martindale, The Extra Pharmacopoeia. London: The Pharmaceutical Press; 1023.
3. Bainhridge PA. 1915 Influence of venous filling upon rate of the heart. J Physiol London 50, 65-84.
4. Balériaux D, Matos C, De Greef D. 1993 Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA. Neuroradiol 35, 490-494.
5. Bokenes J, Hustvedt SO, Refsum H. 1997 Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs. Acad Radiol 4, 204-209.
6. Bourne GW, Trifaro JM. 1982 The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells. Neurosci 7, 1615-1622.
7. Cacheris WP, Quay SC, Rocklage SM. 1990 The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8, 467-481.
8. Corot C, Hentsch AM, Curtelin L. 1994 Interaction of gadolinium complexes with metal-dependent biological systems. Invest Radiol 29, S164-S167.
9. Evans CH. 1990 Biochemistry of the Lanthunides. New York: Plenum Press.
10. Fukuda S, Yamagiwa J, Iida H. 1986 Effect of intravenously injected DTPA on cardiovascular system in rats. Hoken Butsuri 21, 245-250.
11. Geschwind JFH, Saeed M, Wendland MF, Szolar D, Derugin N, Higgins CB. 1996 Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study. Acad Radiol 3, 667-677.
12. Gross DR. 1994 Animal Models in Cardiovascular Research. Dordrecht: Kluwer Academic Publ.
13. Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. 1993 Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28, S28-S43.
14. Hattner R, White D. 1990 Gallium/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of gallium-67. J Nucl Med 31, 1844-1846.
15. Hieronim DE, Kanal E, Swanson DP. 1995 Dosage of gadoteridol and adverse reactions relative to gadopentetate. Am J Health-Syst Pharm 52, 2556-2559.
16. Kasokat T, Urich K. 1992 Quantification of dechelation of gadopentetate dimeglumine in rats. Arzneimittel-Forsch 42, 869-876.
17. Krasnow N. 1972 Effects of lanthanum and gadolinium ions on cardiac sarcoplasmic reticulum. Biochim Biophys Acta 282, 187-194.
18. Langer GA. 1990 Calcium exchange and contractile control. In: Langer GA. ed. Calcium and the Heart. New York: Raven Press; 355-378.
19. Lauffer RB. 1987 Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87, 901-927.
20. Li HT, Saeed M, Wendland MF, Higgins CB. 1993 Cardiovascular responses after ionic and nonionic magnetic resonance contrast media in rats with acute myocardial infarction. Invest Radiol 28, 11-19.
21. Masui T, Takehara Y, Aoshima R, Kaneko M. 1995 Acute hemodynamic effects of intravenous bolus injection of ionic and nonionic magnetic resonance contrast media. Acad Radiol 2, 148-153.
22. Milliken GA. 1990 Analysis of repeated measures design. In: Berry DA. ed. Statistical Methodology in the Pharmaceutical Sciences. New York: Dekker; 83-116.
23. Mühler A, Saeed M, Brasch RC, Higgins CB. 1992a Hemodynamic effects of bolus injection of gadodiamide and gadopentetate dimeglumine as contrast media at MR imaging in rats. Radiology 183, 523-528.
24. Mühler A, Saeed M, Brasch RC, Higgins CB. 1992b Amelioration of cardiodepressive effects of gadopentate dimeglumine with addition of ionic calcium. Radiology 184, 159-164.
25. Niendorf HP, Brasch RC. 1993 Gd-DTPA tolerance and clinical safety. In: Brasch RD ed. MRI Contrast Enhancement in the Central Nervous System: A Case Study Approach. New York: Raven Press, pp 11-21.
26. Oksendal A, Hals PA. 1993 Biodistribution and toxicity of MR imaging contrast media. J Magn Reson Im 3, 157-165.
27. Pang SC, Scott TM. 1980 Use of the common carotid artery in blood pressure measurement in rats. A possible source of error. Can J Physiol Pharmacol 58, 1126-1127.
28. Puttagunta NR, Gibby WA, Smith GT. 1996a Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Invest Radiol 31, 739-742.
29. Puttagunta NR, Gibby WA, Puttagunta VL. 1996b Comparative transmetallation kinetics and thermodynamic stability of gadolinium DTPA bis-glucosamide and other magnetic resonance imaging contrast media. Invest Radiol 31, 619-624.
30. Rinck PA. 1993 Magnetic Resonance in Medicine. The Basic Textbook of the European Magnetic Resonance Forum. Oxford: Blackwell.
31. Runge VM, Wells JW. 1995 Update: safety, new applications, new MR agents. Top Magn Res Imaging 7, 181-195.
32. Rushmer RF. 1970 Cardiovascular Dynamics. Philadelphia: W.B. Saunders.
33. Scott EM. 1983 Reflex control of the cardiovascular system and its modification. Some implications for pharmacologists. J Anton Pharmacol 3, 113-126.
34. Triggle DJ. 1996 The classification of calcium antagonists. J Cardiovasc Pharmacol 27, S11-S16.
35. Tweedle MF. 1991 Nonionic or neutral? Radiology 178, 891.
36. Tweedle MF, Wedeking P, Kumar K. 1995 Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Invest Radiol 30, 372-389.
37. VanWagoner M, O'Toole M, Worah D, Leese PT, Quay SC. 1991 A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent. Invest Radiol 26, 980-986.
38. Waynforth HB. 1980 Experimental and Surgical Technique in the Rat. London: Academic Press.